Significance of Cu/Zn-Superoxide Dismutase Levels in Hemodialysis Patients: A Mini Review
暂无分享,去创建一个
Y. Kiuchi | Hiromichi Gotoh | I. Ohsawa | M. Inagaki | Mayumi Tsuji | Yuya Nakamura | Yoshikazu Goto | T. Oguchi | Naoki Sato | Sachiyo Kenmotsu | Shiho Yamadera
[1] D. Pawlak,et al. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients? , 2013, Life sciences.
[2] D. Pawlak,et al. The alteration in Cu/Zn superoxide dismutase and adhesion molecules concentrations in diabetic patients with chronic kidney disease: the effect of dialysis treatment. , 2012, Diabetes research and clinical practice.
[3] 鷲尾 和則. Correlation between leukocyte membrane lipid peroxidation and expression of Cu/Zn-superoxide dismutase mRNA in hemodialysis patients , 2012 .
[4] D. Pawlak,et al. Systemic Levels of MMP2/TIMP2 and Cardiovascular Risk in CAPD Patients , 2010, Nephron Clinical Practice.
[5] A. Kowalewska,et al. Kynurenine and Its Metabolites—Kynurenic Acid and Anthranilic Acid are Associated With Soluble Endothelial Adhesion Molecules and Oxidative Status in Patients With Chronic Kidney Disease , 2009, The American journal of the medical sciences.
[6] D. Pawlak,et al. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease. , 2009, Thrombosis research.
[7] D. Pawlak,et al. Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. , 2009, Atherosclerosis.
[8] L. Chyczewskî,et al. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. , 2008, Thrombosis research.
[9] D. Pawlak,et al. Erythropoietin Therapy Decreased Tissue Factor, Its Pathway Inhibitor, and Oxidative Stress in Peritoneal Dialysis Patients with Diabetes , 2007, Nephron Clinical Practice.
[10] D. Pawlak,et al. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease. , 2007, Clinical biochemistry.
[11] D. Pawlak,et al. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. , 2007, Atherosclerosis.
[12] D. Pawlak,et al. Carotid atherosclerosis is associated with enhanced beta-chemokine levels in patients on continuous ambulatory peritoneal dialysis. , 2006, Atherosclerosis.
[13] D. Pawlak,et al. Oxidative stress effects fibrinolytic system in dialysis uraemic patients. , 2006, Thrombosis research.
[14] T. Gotoh,et al. Comparison of Effect of Vitamin E-Coated Dialyzer and Oral Vitamin E on Hemodialysis-Induced Cu/Zn-Superoxide Dismutase , 2005, American Journal of Nephrology.
[15] D. Pawlak,et al. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. , 2005, Clinical biochemistry.
[16] D. Pawlak,et al. Circulating β-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients – Role of oxidative stress , 2005 .
[17] T. Gotoh,et al. mRNA Study on Cu/Zn Superoxide Dismutase Induction by Hemodialysis Treatment , 2005, Nephron Clinical Practice.
[18] D. Pawlak,et al. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure]. , 2005, Polskie Archiwum Medycyny Wewnetrznej.
[19] D. Pawlak,et al. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress. , 2005, Cytokine.
[20] D. Pawlak,et al. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients. , 2004, Cytokine.
[21] D. Pawlak,et al. Possible New Role of Monocyte Chemoattractant Protein-1 in Hemodialysis Patients with Cardiovascular Disease , 2004, American Journal of Nephrology.
[22] D. Pawlak,et al. Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients , 2004, Thrombosis and Haemostasis.
[23] D. Pawlak,et al. Oxidative Stress Influences CC-Chemokine Levels in Hemodialyzed Patients , 2004, Nephron Physiology.
[24] M. Myśliwiec,et al. Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients. , 2003, Thrombosis research.
[25] V. Armstrong,et al. No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells , 2002, Journal of internal medicine.
[26] M. Myśliwiec,et al. RELATIONS BETWEEN OXIDATIVE STRESS, HEPATOCYTE GROWTH FACTOR, AND LIVER DISEASE IN HEMODIALYSIS PATIENTS , 2002, Renal failure.
[27] S. Liou,et al. Increase in Resting Levels of Superoxide Anion in the Whole Blood of Uremic Patients on Chronic Hemodialysis , 1998, Blood Purification.
[28] T. Simić,et al. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. , 1995, Clinical Nephrology.
[29] M. C. Albertini,et al. Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. , 1994, Acta haematologica.
[30] A. Fukatsu,et al. Plasma levels of superoxide dismutase and its isomers in patients with chronic renal disease. , 1993, Nihon Jinzo Gakkai shi.